Learn More
Invitrogen™ NRXN1 Recombinant Rabbit Monoclonal Antibody (22H29L23)
Rabbit Recombinant Monoclonal Antibody
Brand: Invitrogen™ 703650
Description
This antibody is predicted to react with Monkey, Cat, Sheep. Recombinant rabbit monoclonal antibodies are produced using in vitro expression systems. The expression systems are developed by cloning in the specific antibody DNA sequences from immunoreactive rabbits. Then, individual clones are screened to select the best candidates for production. The advantages of using recombinant rabbit monoclonal antibodies include: better specificity and sensitivity, lot-to-lot consistency, animal origin-free formulations, and broader immunoreactivity to diverse targets due to larger rabbit immune repertoire.
Neuronal cell surface protein that may be involved in cell recognition and cell adhesion by forming intracellular junctions through binding to neuroligins. May play a role in formation or maintenance of synaptic junctions. May mediate intracellular signaling. May play a role in angiogenesis.
Specifications
| NRXN1 | |
| Recombinant Monoclonal | |
| 0.5 mg/mL | |
| PBS with 0.09% sodium azide; pH 7.4 | |
| P58400, Q9ULB1 | |
| Nrxn1 | |
| Peptides corresponding to human NRXN1 [aa296-aa313, aa394-aa406]. | |
| 100 μg | |
| Primary | |
| Human | |
| Antibody | |
| IgG |
| Immunocytochemistry, Immunofluorescence | |
| 22H29L23 | |
| Unconjugated | |
| Nrxn1 | |
| 1700062G21Rik; 9330127H16Rik; A230068P09Rik; alpha-latrotoxin receptor (calcium-dependent); DKFZp313P2036; FLJ35941; Hs.22998; Kiaa0578; mKIAA0578; neurexin 1; Neurexin 1alpha; neurexin I; neurexin I-alpha; Neurexin I-beta; neurexin-1; Neurexin-1-alpha; neurexin-1-beta; non-processed neurexin I-alpha; Nrxn1; Nrxn1b; PTHSL2; SCZD17 | |
| Rabbit | |
| Protein A | |
| RUO | |
| 9378 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
Your input is important to us. Please complete this form to provide feedback related to the content on this product.